Literature DB >> 17409759

Solitary intracranial Castleman's disease, plasma cell variant: a case report.

A A Mallik1, K C Katchy, N Clotan.   

Abstract

OBJECTIVE: We report a case of plasma cell variant of Castleman's disease confined to the meninges. CLINICAL PRESENTATION AND INTERVENTION: A 53-year-old woman presented with severe headache lasting a few months, which was insidious in onset but followed a progressive course with associated vomiting, blurring of vision and diplopia. Investigations revealed a dural-based mass that was considered both radiologically and intraoperatively as a meningioma. Total surgical excision of the mass was performed. Histologically, it was a plasma cell variant of Castleman's disease with kappa light chain restriction. Laboratory investigations and whole body computerized tomography scan showed no significant abnormality. A short course of local radiotherapy was given. The patient is well 2 years after treatment.
CONCLUSION: This report highlights the rarity of solitary intracranial Castleman's disease and the difficulty in radiological and intraoperative diagnosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17409759     DOI: 10.1159/000100395

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  3 in total

Review 1.  Castleman's disease--a two compartment model of HHV8 infection.

Authors:  Klaus-Martin Schulte; Nadia Talat
Journal:  Nat Rev Clin Oncol       Date:  2010-07-06       Impact factor: 66.675

2.  Meningeal Castleman's disease with multifocal involvement: a case report and review of literature.

Authors:  Santiago Coca; Isabel Salas; Roberto Martínez; Miguel Angel Saez; Jesús Vaquero
Journal:  J Neurooncol       Date:  2008-01-18       Impact factor: 4.130

3.  Resection of unicentric interlobar Castleman disease with following adjuvant radiotherapy.

Authors:  Bruno Sarana; Jana Jaal; Hannes Tamm; Tanel Laisaar
Journal:  SAGE Open Med Case Rep       Date:  2017-11-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.